Insulin-Sensitizers, Polycystic Ovary Syndrome and Gynaecological Cancer Risk

Preclinical, early phase clinical trials and epidemiological evidence support the potential role of insulin-sensitizers in cancer prevention and treatment. Insulin-sensitizers improve the metabolic and hormonal profile in PCOS patients and may also act as anticancer agents, especially in cancers ass...

Descripción completa

Detalles Bibliográficos
Autores principales: Lauretta, Rosa, Lanzolla, Giulia, Vici, Patrizia, Mariani, Luciano, Moretti, Costanzo, Appetecchia, Marialuisa
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi Publishing Corporation 2016
Materias:
Review Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5048026/
https://www.ncbi.nlm.nih.gov/pubmed/27725832
http://dx.doi.org/10.1155/2016/8671762

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5048026/
https://www.ncbi.nlm.nih.gov/pubmed/27725832
http://dx.doi.org/10.1155/2016/8671762

Ejemplares similares